Tag: pediatric
On April 29, 2024, The US Food and Drug Administration (FDA) has accepted a Supplemental New Drug Application for tapinarof cream, 1%, for the topical treatment of atopic dermatitis in adults and children aged ≥ 2 years, according to an announcement by the manufacturer, Dermavant Sciences. Tapinarof cream, 1% (VTAMA) is a steroid-free aryl hydrocarbon […]
Single-strain probiotic treatment had a positive impact on atopic dermatitis (AD) in pediatric patients, according to a study published in Clinical and Translational Allergy.1 The researchers noted that probiotics gained attention for AD treatment after a study found that they helped to reduce eczema in high-risk infants by half.2 “Probiotics may actively fight pathogenic bacteria by […]
Maui Derm’s NP+PA Summer 2022 Conference began with clinical updates on top articles from this year’s literature to provide advanced insights, including updates on pediatric dermatology. Sharing his expertise was James Treat, MD, professor of clinical pediatrics and dermatology and education director, pediatric dermatology at Children’s Hospital of Philadelphia, the HUB for Clinical Collaboration in […]
Korey Capozza, MPH, the founder and executive director of Global Parents for Eczema Research, explores the hidden burdens of itch that many pediatric patients and parents have to deal with on a daily basis. She expanded on her talk from the 4th annual Revolutionizing Atopic Dermatitis (RAD) conference was held from April 9 to 11 […]